Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Diabetes Care|May 13, 2010
Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort databaseEdward S Horton, Cheryl Silberman, Keith L Davis, et al.
Obesity (Silver Spring, Md.)|February 6, 2010
Effects of adiposity and 30 days of caloric restriction upon protein metabolism in moderately vs. severely obese womenGregory C Henderson, Daniel Nadeau, Edward S Horton, et al.
Current Medical Research and Opinion|June 18, 2004
Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetesEdward S Horton, James E Foley, Sharon G Shen, et al.
Obesity Research|August 4, 2005
Troglitazone-induced changes in adiponectin do not affect endothelial function in diabetesJon Buras, Wende R Reenstra, Daniel Orlow, et al.
Diabetology & Metabolic Syndrome|July 23, 2013
Young Hispanics at risk of type 2 diabetes display endothelial activation, subclinical inflammation and alterations of coagulation and fibrinolysisCarlos O Mendivil, Ludivina Robles-Osorio, Edward S Horton, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetesPanayiotis A Economides, Antonella Caselli, Elizabeth Tiani, et al.
Diabetes Care|September 29, 2004
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetesGreeshma K Shetty, Panayiotis A Economides, Edward S Horton, et al.
Microvascular Research|December 26, 2001
The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivityKarim Abou-Elenin, Antonios Xydakis, Osama Hamdy, et al.
Journal of the American College of Cardiology|August 30, 2008
The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in miceGabriela Orasanu, Ouliana Ziouzenkova, Pallavi R Devchand, et al.
Diabetes Technology & Therapeutics|March 10, 2010
STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjectsStephen N Davis, Edward S Horton, Tadej Battelino, et al.
Pageof 8